| NR2F1, a tumor dormancy marker, is expressed predominantly in cancer-associated fibroblasts and is associated with suppressed breast cancer cell proliferation R Wu, AM Roy, Y Tokumaru, S Gandhi, M Asaoka, M Oshi, L Yan, ... Cancers 14 (12), 2962, 2022 | 21 | 2022 |
| Clinical implications of loss of bone marrow minimal residual disease negativity in multiple myeloma M Mohan, S Kendrick, A Szabo, N Yarlagadda, D Atwal, Y Pandey, A Roy, ... Blood Advances 6 (3), 808-817, 2022 | 19 | 2022 |
| Systemic therapy de-escalation in early-stage triple-negative breast cancer: dawn of a new era? RK Gupta, AM Roy, A Gupta, K Takabe, A Dhakal, M Opyrchal, P Kalinski, ... Cancers 14 (8), 1856, 2022 | 17 | 2022 |
| Neoadjuvant cabozantinib in renal-cell carcinoma: a brief review AM Roy, A Briggler, D Tippit, K Dawson, R Verma Clinical Genitourinary Cancer 18 (6), e688-e691, 2020 | 14 | 2020 |
| Acquired amegakaryocytic thrombocytopenia misdiagnosed as immune thrombocytopenia: a case report AM Roy, M Konda, GK Sidarous, D Atwal, SA Schichman, A Kunthur The Permanente Journal 24, 2020 | 12 | 2020 |
| Health-related quality of life (HRQoL) in neuroendocrine tumors: a systematic review R Gosain, M Gupta, AM Roy, J Strosberg, KM Glaser, R Iyer Cancers 14 (6), 1428, 2022 | 11 | 2022 |
| The clinical relevance of unfolded protein response signaling in breast cancer M Oshi, AM Roy, S Gandhi, Y Tokumaru, L Yan, A Yamada, I Endo, ... American Journal of Cancer Research 12 (6), 2627, 2022 | 9 | 2022 |
| Alpelisib-induced diabetic ketoacidosis in a non-diabetic patient T Fugere, AM Roy, I Makhoul Cureus 13 (11), 2021 | 8 | 2021 |
| E2F target score is associated with cell proliferation and survival of patients with hepatocellular carcinoma K Chida, M Oshi, AM Roy, T Yachi, M Nara, K Yamada, O Matsuura, ... Surgery 174 (2), 307-314, 2023 | 7 | 2023 |
| Audit of cancer clinical trials in India AM Roy, A Mathew Journal of Global Oncology 5, 2019 | 7 | 2019 |
| The extracellular matrix in hepatocellular carcinoma: Mechanisms and therapeutic vulnerability AM Roy, R Iyer, S Chakraborty Cell Reports Medicine, 2023 | 6 | 2023 |
| Undiagnosed Acquired Hemophilia A: Presenting as Recurrent Gastrointestinal Bleeding. A Roy, A Siddiqui, V Anand Cureus 12 (9, e10188), doi:10.7759/cureus.10188, 2020 | 6 | 2020 |
| Bad science in the time of COVID-19 AM Roy, A Mathew Cancer Research, Statistics, and Treatment 3 (3), 434-436, 2020 | 6 | 2020 |
| Acquired hemophilia A Y Pandey, D Atwal, M Konda, A Roy, A Sasapu Baylor University Medical Center Proceedings 33 (1), 71-74, 2020 | 6 | 2020 |
| A review of treatment options in HER2‐low breast cancer and proposed treatment sequencing algorithm AM Roy, VM Kumarasamy, A Dhakal, R O’Regan, S Gandhi Cancer 129 (18), 2773-2788, 2023 | 5 | 2023 |
| Real World Outcomes with Alpelisib in Metastatic Hormone Receptor-Positive Breast Cancer Patients: A Single Institution Experience S Alaklabi, AM Roy, K Attwood, A George, T O'connor, A Early, EG Levine, ... Frontiers in Oncology, 5899, 2022 | 5 | 2022 |
| Intravascular large B-cell lymphoma: A diagnostic dilemma AM Roy, Y Pandey, D Middleton, B Broadfoot, A Sasapu, M Veeraputhiran Cureus 13 (7), 2021 | 5 | 2021 |
| Publication rate and characteristics of cancer clinical trials in India VM Thomas, VM John, SA Alexander, AM Roy, A Mathew Journal of Cancer Policy 26, 100248, 2020 | 5 | 2020 |
| Accelerated glycolysis in tumor microenvironment is associated with worse survival in triple-negative but not consistently with ER+/HER2-breast cancer M Oshi, AM Roy, L Yan, M Sasamoto, Y Tokumaru, R Wu, A Yamada, ... American Journal of Cancer Research 13 (7), 3041, 2023 | 4 | 2023 |
| Epidemiology and factors affecting mortality of hospitalized patients with disseminated intravascular coagulation in the United States AM Roy, M Konda, A Goel, A Sasapu Blood 134, 2404, 2019 | 4 | 2019 |
